文献速递老年慢病共病管理老年综合评估

中老年人多重疾病累积、健康期望寿命与生存的动态关系

Dynamics of multimorbidity, health expectancy, and survival in middle aged and older individuals.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2025-01-01

BACKGROUND: Life expectancy has increased, but such increase has disproportionally expanded the period of life with diseases.…

要点

  • 健康期望寿命越长,多重疾病累积速率反而越快(P<.001)。
  • 较短健康期望寿命与较快多重疾病速率均独立预测更高死亡率(P<.001)。
  • 健康期望寿命较长者生存更久,且健康生活占比与多重疾病速率呈正梯度。

核心结论

  • 延长健康期望寿命可能伴随疾病压缩,即疾病期向生命末期集中。

主要发现

  • 健康期望寿命与多重疾病累积速率呈正相关(P<.001)。
  • 较短健康期望寿命和较快多重疾病累积速率均独立关联更高死亡率(P<.001)。
  • 健康期望寿命与多重疾病速率的交互项与死亡率呈负相关(P<.001)。
  • 限定51岁及以上人群并使用HRS特定权重后结果一致。
  • 健康期望寿命较长者生存更久,几乎不受多重疾病速率影响;健康生活占比与多重疾病速率呈正梯度。

关键数值与推荐

  • 多重疾病以9种慢性病诊断计数定义,健康期望寿命定义为从出生至首次确诊疾病前的年数。
  • 健康生活占比定义为无慢性病生活时间占全部生命时间的百分比。

临床怎么用

  • 在老年医学科评估中,可将健康期望寿命和健康生活占比作为风险分层参考,识别多重疾病快速累积的高危个体。

局限性

  • 原文未报告原始研究的局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Life expectancy has increased, but such increase has disproportionally expanded the period of life with diseases. Whether expanding health expectancy (HE), defined as years of life free of chronic diseases, could also affect rate of multimorbidity accumulation is uncertain. Objective: to investigate the dynamic relationship between HE and rate of multimorbidity accumulation and their impact on survival. METHODS: Four thousand two hundred seventy-four (3511 > 50 years) participants from the Health and Retirement Study (HRS), healthy at baseline and developing at least one disease overtime were included. Mean baseline age was 55.1 years and average follow-up was 9.4 years. Multimorbidity was operationalized as count of diagnosed diseases from a list of nine chronic conditions. HE was operationalized as years from birth until when the first disease was ascertained, and percentage of life in good health calculated as percentage of life lived free of chronic diseases. Mixed models investigated the association between HE and rate of multimorbidity accumulation, while survival analyses evaluated association with time to death. RESULTS: HE were positively associated with multimorbidity rate (P < .001). Shorter HE and faster multimorbidity rate were independently associated with higher mortality (P < .001). Their interaction was negatively associated with mortality (P < .001). Results were confirmed restricting the analysis to individuals 51 or older and using HRS specific weights. Individuals with longer HE experienced a greater survival, almost regardless of multimorbidity rate, while a positive gradient was found in percentage of life in good health linked to multimorbidity rate. CONCLUSIONS: Expanding health expectancy is likely followed by compression of morbidity.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Fabbri E, Candia J, Tanaka T, et al. Dynamics of multimorbidity, health expectancy, and survival in middle aged and older individuals. J Gerontol A Biol Sci Med Sci. 2025. PMID: 40729272. doi:10.1093/gerona/glaf164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。